John Simard X Biotech Inc. (XBIT) insider trading activity

XBIT Quotes by TradingView

John Simard is Chief Executive Officer of XBiotech Inc.. Currently has a direct ownership of 3.82 Million shares of XBIT, which is worth approximately $27.4 Million. The most recent transaction as insider was on Oct 18, 2021, when has been sold 33,000 shares (Common Stock) at a price of $13.07 per share, resulting in proceeds of $431,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.82M
0% 3M change
0% 12M change
Total Value Held $27.4 Million

JOHN SIMARD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 18 2021
SELL
Open market or private sale
$431,310 $13.07 p/Share
33,000 Reduced 0.86%
3,823,166 Common Stock
Oct 15 2021
SELL
Open market or private sale
$226,440 $13.32 p/Share
17,000 Reduced 0.44%
3,856,166 Common Stock
Oct 14 2021
SELL
Open market or private sale
$272,512 $12.9 p/Share
21,125 Reduced 0.54%
3,873,166 Common Stock
Oct 13 2021
SELL
Open market or private sale
$139,526 $12.83 p/Share
10,875 Reduced 0.27%
3,962,452 Common Stock
Oct 12 2021
SELL
Open market or private sale
$229,860 $12.77 p/Share
18,000 Reduced 0.45%
3,973,166 Common Stock
Oct 07 2021
SELL
Open market or private sale
$489,111 $12.45 p/Share
39,286 Reduced 0.99%
3,923,166 Common Stock
Oct 06 2021
SELL
Open market or private sale
$134,246 $12.53 p/Share
10,714 Reduced 0.27%
3,962,452 Common Stock
Oct 05 2021
SELL
Open market or private sale
$180,000 $12.66 p/Share
14,218 Reduced 0.36%
3,973,166 Common Stock
Oct 04 2021
SELL
Open market or private sale
$309,747 $13.08 p/Share
23,681 Reduced 0.59%
3,987,384 Common Stock
Oct 01 2021
SELL
Open market or private sale
$260,419 $13.23 p/Share
19,684 Reduced 0.49%
4,011,065 Common Stock
Sep 30 2021
SELL
Open market or private sale
$242,553 $13.07 p/Share
18,558 Reduced 0.46%
4,030,749 Common Stock
Sep 29 2021
SELL
Open market or private sale
$219,870 $13.41 p/Share
16,396 Reduced 0.4%
4,049,307 Common Stock
Sep 28 2021
SELL
Open market or private sale
$89,373 $14.27 p/Share
6,263 Reduced 0.15%
4,065,703 Common Stock
Sep 27 2021
SELL
Open market or private sale
$442,671 $14.81 p/Share
29,890 Reduced 0.73%
4,071,966 Common Stock
Sep 24 2021
SELL
Open market or private sale
$165,447 $14.49 p/Share
11,418 Reduced 0.28%
4,101,856 Common Stock
Sep 23 2021
SELL
Open market or private sale
$145,215 $14.68 p/Share
9,892 Reduced 0.24%
4,113,274 Common Stock
Sep 22 2021
SELL
Open market or private sale
$297,789 $15.14 p/Share
19,669 Reduced 0.47%
4,123,166 Common Stock
Sep 21 2021
SELL
Open market or private sale
$256,946 $15.24 p/Share
16,860 Reduced 0.41%
4,142,835 Common Stock
Sep 20 2021
SELL
Open market or private sale
$202,873 $15.06 p/Share
13,471 Reduced 0.32%
4,159,695 Common Stock
Jul 14 2021
SELL
Open market or private sale
$907,500 $18.15 p/Share
50,000 Reduced 1.18%
4,173,166 Common Stock
Mar 22 2021
BUY
Exercise of conversion of derivative security
$3,750,000 $7.5 p/Share
500,000 Added 10.59%
4,223,166 Common Shares
JS

John Simard

Chief Executive Officer
Austin, TX

Track Institutional and Insider Activities on XBIT

Follow XBiotech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XBIT shares.

Notify only if

Insider Trading

Get notified when an X Biotech Inc. insider buys or sells XBIT shares.

Notify only if

News

Receive news related to XBiotech Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XBIT